Lupin Limited today announced that its alliance partner Caplin Steriles Limited (Caplin) has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Thiamine Hydrochloride Injection USP, via an exchange filing.
The approved dosages are 200 mg/2 mL (100 mg/mL) Multiple-dose Vials, to market a therapeutically equivalent to the reference listed drug (RLD), Thiamine Hydrochloride Injection USP, 200 mg/2 mL (100mg/mL), of Fresenius Kabi USA LLC.
Thiamine Hydrochloride Injection USP had an annual sale of approximately USD 36 million in the U.S. (IQVIA MAT for the 12-month period ending December 2022).
Uttar Pradesh News: Groom Walks Away 18 Hours After Wedding In Jhansi Over Caste Dispute
'One Tree For Mother': Uttar Pradesh Targets Historic Tree Plantation To Combat Climate Crisis
President Droupadi Murmu Calls For Fundamental Rethink Of Humanity-Animal-Nature Relationship At IVRI Convocation In Bareilly
Tragic! 7-Year-Old Boy Crushed To Death By 'Toyota Innova' SUV While Playing In Telangana's Nizamabad; CCTV VIDEO Surfaces
